"Cancer isn't just a medical condition. It's also a life-changing journey for many. From the moment of diagnosis, we are with you, offering expert medical care, understanding and support. At M Health Fairview Cancer Care, we stay on the leading edge, offering advanced options for diagnosis and treatment. Whether you need an initial diagnosis or a second opinion, we’re here to help. Please note: This cancer center is located within M Health Fairview St. John's Hospital."

During the past decade, HealthEast Cancer Care at St. John's Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 80 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 13 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "HealthEast Cancer Care at St. John's Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 63 trials, followed by "Eastern Cooperative Oncology Group" with 20 trials sponsored, "SWOG Cancer Research Network" with 14 trials sponsored, "NSABP Foundation Inc" with 8 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "HealthEast Cancer Care at St. John's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 116 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator and "Eastern Cooperative Oncology Group" with 4 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "HealthEast Cancer Care at St. John's Hospital" are "Breast Cancer" (27 trials), "Lung Cancer" (18 trials), "Lymphoma" (11 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (11 trials) and "Leukemia" (9 trials). Many other conditions were trialed in "HealthEast Cancer Care at St. John's Hospital" in a lesser frequency.

Most popular intervention types in "HealthEast Cancer Care at St. John's Hospital" are "Drug" (98 trials), "Biological" (43 trials), "Other" (32 trials), "Radiation" (21 trials) and "Procedure" (10 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (23 trials), "bevacizumab" (15 trials), "cyclophosphamide" (12 trials), "radiation therapy" (11 trials) and "carboplatin" (10 trials). Other intervention names were less common.

The vast majority of trials in "HealthEast Cancer Care at St. John's Hospital" are 97 trials for "All" genders, 16 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "HealthEast Cancer Care at St. John's Hospital". undefined are not yet recruiting, undefined are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 91 completed trials in HealthEast Cancer Care at St. John's Hospital, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in HealthEast Cancer Care at St. John's Hospital, 4 "Phase 1" clinical trials were conducted, 63 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".